Trustworthy pediatric screening AI needs more than accuracy: label validity, calibration, subgroup robustness, and clinical-scope limits. We propose Clear-Rd ( Clinical Leakage Evaluation and Audit Routine for Rule-Derived labels ), a five-stage framework—Configure, Lift, Evaluate, Audit, Report—and apply it to two public autism-screening datasets—Q-CHAT-10 toddler ( N = 1054) and AQ-10 child/adolescent/adult ( N = 6075)—merged into a unified cohort ( N = 7129); prior studies report accuracies above 95%. Three configurations— S 1 (full, with score), S 2 (items, no score), and S 3 (demographics only)—separate label leakage from demographic signal. A leakage audit confirms the Q-CHAT-10 label is exactly determined by score>3, the AQ-10 label approximately by score≥6. Sixteen models from three families (classical, deep-tabular, and prompt-structure simulators) are evaluated under 5-fold stratified cross-validation. On the leakage-free S 3 , Gradient Boosting attains ROC-AUC 0.766 ± 0.005 and all families converge within 0.04 ROC-AUC, indicating the binding constraint is the feature set, not model capacity. Calibration, subgroup-parity, and cost-sensitive analyses complete the audit. The results expose a gap between reported and clinically interpretable performance; Clear-Rd is a reusable template for rule-derived medical labels. No such model should be interpreted as predicting clinical autism diagnosis without external validation against gold-standard outcomes.
No takes yet. Share an insight, caveat, or question.
Ammar et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: